Declan C.T. Lavoie

Statistics

Publications

Citations

210

H-Index

Active since

2022

Affiliations

Population Health Research Institute(Current)

Thrombosis and Atherosclerosis Research Institute

Esperion Therapeutics (United States)

McMaster University

Declan C.T. Lavoie is an author at Population Health Research Institute specializing in hepatic metabolic regulation, hepatic pathophysiology, and liver disease.

Publications per year

2022–2023

Publications

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia

Marisa R. Morrow, Battsetseg Batchuluun, Jianhan Wu et al. · Cell Metabolism · 2022 · 180 citations

Life Sciences, Biochemistry, Pharmacology +12

Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice

Eric M. Desjardins, Jianhan Wu, Declan C.T. Lavoie et al. · Cell Reports Medicine · 2023 · 30 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

1–2 of 2